Cargando…

Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial

OBJECTIVE: To evaluate if nebulised surfactant reduces intubation requirement in preterm infants with respiratory distress treated with nasal continuous positive airway pressure (nCPAP). DESIGN: Double blind, parallel, stratified, randomised control trial. SETTING: Sole tertiary neonatal unit in Wes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minocchieri, Stefan, Berry, Clare A, Pillow, J Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764249/ https://www.ncbi.nlm.nih.gov/pubmed/30049729 http://dx.doi.org/10.1136/archdischild-2018-315051

Ejemplares similares

Correction: Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial
Publicado: (2020)

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
por: Dixon, Barry, et al.
Publicado: (2021)

Treatment of asthma exacerbations with the human-powered nebuliser: a randomised parallel-group clinical trial
por: Hallberg, Christopher J, et al.
Publicado: (2014)

Dexmedetomidine nebulisation attenuates post-operative sore throat in patients undergoing thyroidectomy: A randomised, double-blind, comparative study with nebulised ketamine
por: Thomas, Derlin, et al.
Publicado: (2020)

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
por: Twiss, Jacob, et al.
Publicado: (2022)

Nebulised fentanyl for post-operative pain relief, a prospective double-blind controlled randomised clinical trial
por: Singh, Anil P, et al.
Publicado: (2013)

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020)

Comments on “Nebulised fentanyl for post operative pain relief, a prospective double blind controlled randomised clinical trial”
por: Mather, Laurence E
Publicado: (2014)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Response to comments: Nebulised fentanyl for post-operative pain relief, a prospective double-blind controlled randomised clinical trial
por: Singh, Anil P, et al.
Publicado: (2014)

Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Bardsley, George, et al.
Publicado: (2018)

Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial
por: Rakshasbhuvankar, Abhijeet, et al.
Publicado: (2017)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
por: Khanal, Aayush, et al.
Publicado: (2015)

Nebulised dexmedetomidine for patient’s comfort and satisfaction during diagnostic upper gastrointestinal endoscopy: A double-blind randomised controlled study
por: Sriramka, Bhavna, et al.
Publicado: (2023)

A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome
por: Rebello, Celso Moura, et al.
Publicado: (2014)

Preoperative lignocaine nebulisation for attenuation of the pressor response of laryngoscopy and tracheal intubation in patients with severe preeclampsia undergoing caesarean section delivery: A randomised double-blind controlled trial
por: Nabil, Fatma, et al.
Publicado: (2023)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome
por: Somaschini, Marco, et al.
Publicado: (2017)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
por: Alton, Eric W F W, et al.
Publicado: (2015)

Role of nebulised dexmedetomidine, midazolam or ketamine as premedication in preschool children undergoing general anaesthesia—A prospective, double-blind, randomised study
por: Shereef, K Muhammed, et al.
Publicado: (2022)

Nebulised fentanyl, dexmedetomidine and magnesium sulphate for attenuation of haemodynamic response to laryngoscopy and tracheal intubation: A double-blinded, randomised comparative study
por: Grover, Niharika, et al.
Publicado: (2023)

Randomised Comparison between the Efficacy of Two Doses of Nebulised Dexmedetomidine for Premedication in Paediatric Patients
por: Anupriya, Jindal, et al.
Publicado: (2020)

Evaluation of nebulised dexmedetomidine in blunting haemodynamic response to intubation: A prospective randomised study
por: Kumar, Nimmagadda R R, et al.
Publicado: (2020)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis
por: Everard, Mark L, et al.
Publicado: (2014)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
por: Lategan, Ilse, et al.
Publicado: (2023)

Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial
por: Szupieńko, Sara, et al.
Publicado: (2023)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Diagnostic Value of Surfactant Protein-A in Severe Acute Pancreatitis-Induced Acute Respiratory Distress Syndrome
por: Zhu, Bin, et al.
Publicado: (2014)

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study
por: Möller, Jens Christian, et al.
Publicado: (2003)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020)

Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
por: Dhiman, Tanvi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1sr4gte03hsoamhvn97kg1orgl